Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | SOD1 | P00441 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | TDO2 | P48775 | 1/20 | 0.32 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.31 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.31 |
| ▸ | ITGAV | P06756 | 1/20 | 0.31 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | RXRB | P28702 | 1/20 | 0.31 |
| ▸ | RXRG | P48443 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.30 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6914024 | 0.84 | KIF11 (0.42) | IDO1CES2SOD1 | |
| SCHEMBL6675245 | 0.83 | IDO1 (0.31) | IDO1SOD1 | |
| SCHEMBL4444280 | 0.81 | CES2 (0.41) | IDO1CES2SOD1MAPTITGB3 | |
| SCHEMBL466921 | 0.81 | CES2 (0.41) | IDO1CES2SOD1TDO2MAPT | |
| SCHEMBL4245131 | 0.80 | IDO1 (0.33) | IDO1SOD1 | |
| SCHEMBL23633171 | 0.79 | CES2 (0.40) | IDO1CES2SOD1TDO2MAPT | |
| SCHEMBL646925 | 0.79 | IDO1 (0.36) | IDO1CES2SOD1GPR84TDO2 | |
| Lithium Ion SCHEMBL29870237 | 0.79 | IDO1 (0.36) | IDO1CES2SOD1GPR84TDO2 | |
| SCHEMBL646926 | 0.79 | CES2 (0.40) | IDO1CES2SOD1TDO2MAPT | |
| SCHEMBL30473264 | 0.79 | CES2 (0.45) | IDO1CES2SOD1TDO2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023073691-A1 | WEARABLE MICRONEEDLES-BASED EXTENDED GATE FIELD-EFFECT TRANSISTOR FOR REAL-TIME DETECTION OF BIOMARKERS FROM INTERSTITIAL FLUID | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LIMITED (IL) | 2023-05-04 | — | — | WO | claimed |
| US-11121407-B2 | Electrolytes for stable cycling of high capacity lithium based batteries | ZENLABS ENERGY, INC. (US) | 2021-09-14 | — | — | US | claimed |
| US-20190348715-A1 | ELECTROLYTES FOR STABLE CYCLING OF HIGH CAPACITY LITHIUM BASED BATTERIES | IONBLOX, INC. | 2019-11-14 | — | — | US | claimed |
| US-9184428-B2 | Non-aqueous electrolytes for lithium ion batteries | UCHICAGO ARGONNE LLC (US) | 2015-11-10 | — | — | US | claimed |
| US-8957172-B2 | Nonsymmetric catalysts comprising salan ligands | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-02-17 | — | — | US | claimed |
| US-20150037690-A1 | ELECTROLYTES FOR STABLE CYCLING OF HIGH CAPACITY LITHIUM BASED BATTERIES | IONBLOX, INC. | 2015-02-05 | — | — | US | claimed |
| US-20130337345-A1 | OXIDE ANODE MATERIALS FOR LITHIUM BATTERIES | ENERGY, UNITED STATES DEPARTMENT OF | 2013-12-19 | — | — | US | claimed |
| WO-2012138844-A2 | NON-AQUEOUS ELECTROLYTES FOR LITHIUM-AIR BATTERIES | UCHICAGO ARGONNE, LLC (US) | 2012-10-11 | — | — | WO | claimed |
| US-20080318136-A1 | NON-AQUEOUS ELECTROLYTES | UCHICAGO ARGONNE, LLC | 2008-12-25 | — | — | US | claimed |
| WO-2008073664-A1 | POLY(ETHYLENEOXIDE) SILOXANE GEL ELECTROLYTES | UCHICAGO ARGONNE, LLC (US) | 2008-06-19 | — | — | WO | claimed |
| WO-2006101779-A2 | NON-AQUEOUS ELECTROLYTES FOR LITHIUM ION BATTERIES | THE UNIVERSITY OF CHICAGO (US) | 2006-09-28 | — | — | WO | claimed |
| US-20060210883-A1 | Non-aqueous electrolytes for lithium ion batteries | THE UNIVERSITY OF CHICAGO | 2006-09-21 | — | — | US | claimed |
| JP-9127043-A | — | — | None | — | — | JP | disclosed |
| EP-4731080-A2 | BIOSENSOR FOR THE IN VIVO MONITORING OF ELECTROLYTES | Proton Intelligence Inc. (CA) | 2026-04-29 | — | — | EP | disclosed |
| EP-4665774-A1 | METALLOCENE CATALYST COMPOUNDS HAVING FERROCENYL SUBSTITUENTS | ExxonMobil Technology and Engineering Company (US) | 2025-12-24 | — | — | EP | disclosed |
| US-20250319211-A1 | NEAR IR LUMINESCENCE AND OPTICALLY ADDRESSABLE QUANTUM SENSING AND MAGNETIC IMAGING WITH RADICALOID TETRATHIAFULVALENE TETRATHIOLATES | UNIV CHICAGO (US) | 2025-10-16 | — | — | US | disclosed |
| US-5418276-A | Styrene copolymer, syndiotactic, heat resistance, chemical resistance | IDEMITSU KOSAN CO., LTD. (JP) | 1995-05-23 | — | — | US | disclosed |
| US-5362814-A | Styrene polymers with olefin monomers and diolefin monomers for impact strength in molding materials | IDEMITSU KOSAN CO., LTD. (JP) | 1994-11-08 | — | — | US | disclosed |
| EP-0559108-A1 | Graft copolymer, process for production thereof and resin composition containing same | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-09-08 | — | — | EP | disclosed |
| EP-0454231-A2 | Late transition metal catalysts for olefin polymerization | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 1991-10-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250319211-A1 | NEAR IR LUMINESCENCE AND OPTICALLY ADDRESSABLE QUANTUM SENSING AND MAGNETIC IMAGING WITH RADICALOID TETRATHIAFULVALENE TETRATHIOLATES | TRMT1, TPT1, TTI2 | IDO1 449/4885CES2 4683/4885SOD1 164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.